Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$442,566
-$73,516 QoQ
Shares Held
18,379
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,843
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Acropolis Investment Management, LLC holds $13,272,644 across 8 Drug Manufacturers - General names. PFE ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
20,115 | $5,108,606 | |
| 2 | LLY |
ELI LILLY & Co
|
2,014 | $2,415,652 | |
| 3 | ABBV |
AbbVie Inc.
|
7,039 | $1,771,293 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,768 | $1,769,188 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
17,771 | $1,023,965 | |
| 6 | AMGN |
Amgen Inc
|
1,487 | $538,472 | |
| 7 | PFE |
Pfizer Inc
This page
|
18,379 | $442,566 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,606 | $202,902 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $442,566 | 18,379 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $516,082 | 18,379 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $457,114 | 18,358 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $439,249 | 17,239 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $334,148 | 13,785 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $397,027 | 15,668 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $371,897 | 14,018 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $396,593 | 13,704 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $393,174 | 14,052 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $388,139 | 13,987 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $394,250 | 13,694 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $493,602 | 14,881 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $632,509 | 17,244 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $707,920 | 17,351 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $824,605 | 16,093 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $622,442 | 14,224 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $750,220 | 14,309 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $711,785 | 13,749 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $769,067 | 13,024 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $547,732 | 12,735 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $491,614 | 12,554 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $454,758 | 12,552 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $447,278 | 12,151 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $418,930 | 11,415 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $288,054 | 8,809 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $287,460 | 8,807 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||